DK136246B - Fremgangsmåde til fremstilling af N-alkyl-1,4-dihydropyridiner. - Google Patents

Fremgangsmåde til fremstilling af N-alkyl-1,4-dihydropyridiner.

Info

Publication number
DK136246B
DK136246B DK224370AA DK224370A DK136246B DK 136246 B DK136246 B DK 136246B DK 224370A A DK224370A A DK 224370AA DK 224370 A DK224370 A DK 224370A DK 136246 B DK136246 B DK 136246B
Authority
DK
Denmark
Prior art keywords
dihydropyridines
alkyl
preparation
Prior art date
Application number
DK224370AA
Other languages
English (en)
Other versions
DK136246C (da
Inventor
Friedrich Bossert
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK136246B publication Critical patent/DK136246B/da
Application granted granted Critical
Publication of DK136246C publication Critical patent/DK136246C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK224370AA 1969-05-10 1970-05-04 Fremgangsmåde til fremstilling af N-alkyl-1,4-dihydropyridiner. DK136246B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1923990A DE1923990C3 (de) 1969-05-10 1969-05-10 Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern

Publications (2)

Publication Number Publication Date
DK136246B true DK136246B (da) 1977-09-12
DK136246C DK136246C (da) 1978-02-13

Family

ID=5733869

Family Applications (1)

Application Number Title Priority Date Filing Date
DK224370AA DK136246B (da) 1969-05-10 1970-05-04 Fremgangsmåde til fremstilling af N-alkyl-1,4-dihydropyridiner.

Country Status (15)

Country Link
US (1) US3773773A (da)
JP (1) JPS4935277B1 (da)
AT (1) AT299200B (da)
BE (1) BE750139A (da)
BR (1) BR6915159D0 (da)
DE (1) DE1923990C3 (da)
DK (1) DK136246B (da)
FI (1) FI52078C (da)
FR (1) FR2051515B1 (da)
GB (1) GB1305793A (da)
IL (1) IL34304A (da)
NL (1) NL7006628A (da)
NO (1) NO133274C (da)
SE (1) SE376915B (da)
YU (1) YU33268B (da)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963188A1 (de) * 1969-12-17 1971-06-24 Bayer Ag Neue Cyanphenyl-1,4-dihydropyridinderivate
DE2117572C3 (de) * 1971-04-10 1980-03-20 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin ^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
US4021434A (en) * 1972-01-22 1977-05-03 Yamanouchi Pharmaceutical Co., Ltd. Sodium β-[2,6-dimethyl-3,5-bis(ethoxycarbonyl)-4-(3-nitrophenyl)-1,4-dihydropyridine-1-yl]ethyl sulfate
GB1430961A (en) * 1972-01-22 1976-04-07 Yamanouchi Pharma Co Ltd 1-substituted-1,4-dihyddrypyridine derivatives
DD106832A5 (da) * 1972-03-06 1974-07-05
US3933834A (en) * 1972-03-06 1976-01-20 Bayer Aktiengesellschaft Unsymmetrical esters of N-substituted 1,4-dihydropyridine 3,5-dicarboxylic acid
US3992545A (en) * 1972-03-06 1976-11-16 Bayer Aktiengesellschaft 2-Amino-4,5-dihydropyridine derivatives in pharmaceutical compositions
US3985886A (en) * 1972-03-06 1976-10-12 Bayer Aktiengesellschaft 2-Amino-4,5-dihydropyridine derivatives and process for their preparation
US3939171A (en) * 1972-03-06 1976-02-17 Bayer Aktiengesellschaft 2-Amino-1,4-dihydropyridine derivatives
US3957998A (en) * 1972-03-06 1976-05-18 Bayer Aktiengesellschaft Use of 2,6-diamino-4-substituted-1,4-dihydropyridine-3,5-dicarboxylic acid esters for effecting coronary vessel dilation and treating hypertension
US3935223A (en) * 1972-03-06 1976-01-27 Bayer Aktiengesellschaft 2-Amino-1,4-dihydropyridine derivatives
US3857849A (en) * 1973-02-28 1974-12-31 Bayer Ag 2-amino-1,4-dihydropyridine derivatives
US3917620A (en) * 1972-03-06 1975-11-04 Bayer Ag 2-Amino-4,5-dihydropyridine derivatives
US3988458A (en) * 1972-03-06 1976-10-26 Bayer Aktiengesellschaft Bicyclic derivatives of 1,4-dihydropyridine 3,5-carboxylic acid esters
US3887558A (en) * 1972-03-06 1975-06-03 Bayer Ag Process for producing 2,6-diamino -1,4- dihydro-3,5-pyridine-dicarboxylates and derivatives thereof
DE2210674C3 (de) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2-Amino-6-methyl-1,4-dihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2218644C3 (de) * 1972-04-18 1982-08-19 Bayer Ag, 5090 Leverkusen Basische Ester von 1,4-Dihydropyridinen, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2228363A1 (de) * 1972-06-10 1974-01-03 Bayer Ag 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US3968117A (en) * 1972-06-10 1976-07-06 Bayer Aktiengesellschaft 1,4-Dihydropyridines
DE2239815C2 (de) * 1972-08-12 1983-02-10 Bayer Ag, 5090 Leverkusen 2-Alkylamino-dihydropyridine, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
US4136187A (en) * 1972-08-12 1979-01-23 Bayer Aktiengesellschaft Antihypertensive 2-amino-4,5-dihydropyridine derivatives
DE2242787C2 (de) * 1972-08-31 1982-01-21 Bayer Ag, 5090 Leverkusen 4-Phenyl-6-amino-3,4-dihydropyridon-(2)-3,5-dicarbonsäure-diäthylesterderivate, ein Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE2242786A1 (de) * 1972-08-31 1974-03-14 Bayer Ag Verfahren zur herstellung von neuen 2-amino-1,4-dihydropyridinen mit einer carbonylfunktion sowie ihre verwendung als arzneimittel
GB1409865A (en) * 1973-02-13 1975-10-15 Science Union & Cie Dihydropyridines derivatives their preparation and pharmaceu tical compositions containing them
FR2218107A1 (en) * 1973-02-20 1974-09-13 Yamanouchi Pharma Co Ltd Amino alkyl 2,6-dialkyl-4-aryl-1,4 dihydropyridine-3, carboxylates - useful as cerebral vasodilators and musculotropic spasmolytic agents
US4002762A (en) * 1973-03-03 1977-01-11 Bayer Aktiengesellschaft 2-Amino-3,4-dihydropyridines used to effect coronary vessel dilation and treat hypertension
GB1425729A (en) * 1973-06-12 1976-02-18 Smith Kline French Lab 1,4-dihydropyridine compounds
DE2335466A1 (de) * 1973-07-12 1975-01-30 Bayer Ag Alkoxyalkyl-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4020178A (en) * 1973-07-12 1977-04-26 Bayer Aktiengesellschaft 1,4-Dihydropyridine esters used as coronary dilators and anti-hypertensives
FR2320750A1 (fr) * 1975-08-12 1977-03-11 Hexachimie Dihydro-1,4 pyridines et leur application therapeutique
US4466972A (en) * 1977-06-20 1984-08-21 Sandoz Ltd. Benzoxadiazoles and benzothiadiazoles, their preparation and pharmaceutical compositions containing them
DE2738153A1 (de) * 1977-08-24 1979-03-08 Bayer Ag 2-pyridyl-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
FR2405937A1 (fr) * 1977-10-14 1979-05-11 Labaz Nouveaux derives de dihydropyridine, leur procede de preparation et leur application
SU798099A1 (ru) * 1978-03-06 1981-01-23 Ордена Трудового Красного Знамениинститут Органического Синтезаан Латвийской Ccp 1-Бензил-2,6-диметил-4-о-или-M-НиТРОфЕНил-3,5-диэТОКСиКАРбОНил- 1,4-дигидРОпиРидиНы, пРО Вл ющиЕКОРОНАРОдилАТиРующую АКТиВНОСТь
DE3022030A1 (de) * 1980-06-12 1981-12-17 Bayer Ag, 5090 Leverkusen 4-thiazol- bzw. 4-imidazol-substituierte, 1,4-dihydropyridine, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
US4365063A (en) * 1981-08-31 1982-12-21 American Home Products Corporation Antihypertensive agents
US4321384A (en) * 1981-02-27 1982-03-23 American Home Products Corporation Antihypertensive agents
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
JPS58159490A (ja) * 1982-02-23 1983-09-21 Nikken Kagaku Kk １，４−ジヒドロピリジン化合物
US4500532A (en) * 1983-03-03 1985-02-19 Usv Pharmaceutical Corporation 1-(Substituted aminoalkyl)-1,4-dihydropyridines
US4771057A (en) * 1986-02-03 1988-09-13 University Of Alberta Reduced pyridyl derivatives with cardiovascular regulating properties
EP0388482B1 (de) * 1989-03-20 1994-07-06 Siemens Aktiengesellschaft Lichtempfindliches Gemisch
US5258521A (en) * 1989-07-26 1993-11-02 Tosoh Corporation Process of producing optically active propionic acid ester derivatives
DE4011695A1 (de) * 1990-04-11 1991-10-17 Bayer Ag Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsaeureestern als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung
DE4125271A1 (de) * 1991-07-31 1993-02-11 Bayer Ag Neue n-alkylierte 1,4-dihydropyridindicarbonsaeureester
DE4133257A1 (de) * 1991-10-08 1993-04-15 Bayer Ag N-methyl-nimodipin, verfahren zu seiner herstellung und seine verwendung als zerebraltherapeutikum
DE4223867A1 (de) * 1992-07-20 1994-01-27 Bayer Ag Spezieller 1,4-Dihydropyridin-3,5-dicarbonsäureester, Verfahren zu seiner Herstellung und seine pharmazeutische Verwendung
DE4430094A1 (de) * 1994-08-25 1996-02-29 Bayer Ag Verwendung von 3,5-Dicarbonsäureester-1,4-Dihydropyridinen als Arzneimittel
JPH1039510A (ja) * 1996-07-29 1998-02-13 Nitto Denko Corp ネガ型フォトレジスト組成物及びその利用
AU747705C (en) * 1997-12-13 2004-09-23 Bristol-Myers Squibb Company Use of pyrazolo (3,4-b) pyridine as cyclin dependent kinase inhibitors
US6653481B2 (en) * 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine
JP6073913B2 (ja) * 2011-11-24 2017-02-01 リピダート クタトー フェイレサト エス タナチャド カーエフテー． Ｈｓｐ調節活性を有する１，４−ジヒドピリジン誘導体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3325505A (en) * 1965-02-24 1967-06-13 Smith Kline French Lab 4-cycloalkyl(or cycloalkenyl)-dihydropyridines
US3441648A (en) * 1967-02-07 1969-04-29 Smithkline Corp Compositions and methods for lowering blood pressure with 1,4-dihydropyridines

Also Published As

Publication number Publication date
US3773773A (en) 1973-11-20
IL34304A0 (en) 1970-06-17
DK136246C (da) 1978-02-13
NO133274C (da) 1976-04-07
NL7006628A (da) 1970-11-12
FR2051515A1 (da) 1971-04-09
JPS4935277B1 (da) 1974-09-20
SE376915B (da) 1975-06-16
DE1923990B2 (de) 1978-03-30
FI52078C (fi) 1977-06-10
DE1923990C3 (de) 1978-11-23
IL34304A (en) 1973-06-29
DE1923990A1 (de) 1970-11-19
GB1305793A (da) 1973-02-07
FI52078B (da) 1977-02-28
YU102670A (en) 1976-03-31
AT299200B (de) 1972-06-12
BE750139A (da) 1970-11-09
BR6915159D0 (pt) 1973-04-19
YU33268B (en) 1976-08-31
FR2051515B1 (da) 1974-07-12
NO133274B (da) 1975-12-29

Similar Documents

Publication Publication Date Title
DK136246B (da) Fremgangsmåde til fremstilling af N-alkyl-1,4-dihydropyridiner.
DK125794B (da) Analogifremgangsmåde til fremstilling af 2,3-dichlorphenoxyeddikesyrederivater.
DK130306B (da) Analogifremgangsmåde til fremstilling af S-trialkylphosphinguld-1-thio-β-D-glucopyranosider.
DK136314B (da) Analogifremgangsmåde til fremstilling af benzamidoethylpiperaziner.
DK127113B (da) Analogifremgangsmåde til fremstilling af 1,4-dihydropyridiner.
DK128852B (da) Analogifremgangsmåde til fremstilling af svovlholdige 1,4-dihydropyridiner.
DK140697B (da) Fremgangsmåde til fremstilling af 2-amino-4-hydroxy-6-hydroxymethyl-7,7-dimethyl-7,8-dihydropteridin.
DK133375B (da) Analogifremgangsmåde til fremstilling af 1-carbamoyl-3-phenylpyrrolidiner.
DK125089B (da) Analogifremgangsmåde til fremstilling af evomonosidderivater.
DK126944B (da) Analogifremgangsmåde til fremstilling af hexahydrobenzindolderivater.
DK123236B (da) Fremgangsmåde til fremstilling af 2-alkyl-3-hydoxy-4,5-dihydrofuran-4-oner.
DK128006B (da) Analogifremgangsmåde til fremstilling af 11-desacetoxy-wortmannin.
DK121052B (da) Fremgangsmåde til fremstilling af steroid-17α,21-orthocarbonater.
DK128737B (da) Analogifremgangsmåde til fremstilling af 6α-methyl-17α-caproyloxy-19-norprogesteron.
DK123096B (da) Analogifremgangsmåde til fremstilling af neriifolinderivater.
DK122456B (da) Fremgangsmåde til fremstilling af quinoxalin-di-N-oxid-aldehyd.
DK124331B (da) Analogifremgangsmåde til fremstilling af 14β-hydroksy-15α-acyloksy-4,20(22)-kardadienolider.
DK122127B (da) Analogifremgangsmåde til fremstilling af 3-phenyl-4-acyloxycarbostyriler.
DK123816B (da) Analogifremgangsmåde til fremstilling af N-phenacylcarbamater.
DK123818B (da) Fremgangsmåde til fremstilling af 14β-hydroxy-card-20(22)-enolider eller -bufa-20,20-dienolider.
DK139071B (da) Fremgangsmåde til fremstilling af copolymerisater.
DK126186B (da) Fremgangsmåde til fremstilling af 13β-alkylgona-4,9-diener.
DK125790B (da) Fremgangsmåde til fremstilling af L-β-3,4-dihydroxyphenyl-α-alanin.
DK128777B (da) Fremgangsmåde til fremstilling af 3β-alkanoyloxy-6-halogen-pregna-4,6-dien-20-oner.
DK126190B (da) Fremgangsmåde til fremstilling af 4-chlor-14β-hydroxy-carda-4,20(22)-dienolider.